Shenzhen, China, Feb. 20, 2021  — TMFOX VENTURE PARTNERS, a boutique investment bank and venture investor for global healthcare announces that it has entered into an exclusive financial advisory agreement with Balanlife Dialysis Chain (Shenzhen) Co.,ltd for its capital operation including merger and acquisition of specialized chronic disease hospitals, dialysis chain clinics across mainland China, estimated 20 million USD fundraising, and preparation of initial public listing.  

Commenting on the agreement, Wei Liu, Founder of Balanlife, said, “We are delighted to work with TMFOX toward these great objectives With the joint efforts of our two companies, we are confident tremendous success will be achieved and significant benefits will be delivered to patients across China.”

About Balanlife Dialysis

Founded in 2009, Balanlife Dialysis Chain (Shenzhen) Co., Ltd. is a well-known national brand focusing on a chain clinic business for dialysis, with clinics in Guangzhou, Shaoguan, Yunfu, Zhaoqing, Jiangmen, Jieyang, Shantou, Fujian, Hubei, and other places. For more information, please visit http://www.balanlife.com/

About TMFOX VENTURE PARTNERS

TMFOX focuses on the evolution of global Healthcare and is committed to empowering its clients with cross-border funding, business development, and risk management. TMFOX offers holistic solutions that help clients grow competitive in this constantly evolving market. Founded in 2009 in Shenzhen in China by Andy Yu, the boutique investment bank has operations in 6 cities across China and 3 international cities such as Vancouver, Seattle, and Boston in North American.